Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


Phacilitate Leaders Europe Agenda


Closing Panel Discussion: Reimbursement models: How can these help bridge the gap between approved products and patient access

17 Sep 2019
Patient Access & Healthcare
Detlev Parow, Head of the Department of Medicines, Therapeutic Appliances and Remedies - DAK-Gesundheit
Pilar Pinilla Dominguez, Senior Scientific Adviser - NICE Scientific Advice
Alexander Natz, Secretary General - EUCOPE
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd